| 2026-08-26 | Press release | VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets |
| 2026-08-26 | Press release | Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis |
| 2026-08-13 | Press release | VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update |
| 2026-08-12 | Press release | Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients |
| 2026-08-11 | Press release | VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update |
| 2026-08-05 | Press release | Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology |
| 2026-07-30 | Press release | Volition Advances Nu.Q® NETs Platform Towards Commercialization |
| 2026-07-07 | Press release | VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q® Cancer Test |
| 2026-06-17 | Press release | VolitionRx Announces Collaboration with Sysmex |
| 2026-06-07 | Press release | VolitionRx Announces Pricing of $4.6 Million Public Offering |
| 2026-06-03 | Press release | VolitionRx Files New Patent Protecting its Nu.Q® NETs Test for Ebola Triage and Treatment Monitoring |
| 2026-05-27 | Press release | VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets |
| Press release | Read Press Release |
| 2026-05-14 | Press release | PDF |
| Press release | Read Press Release |
| Press release | VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update |
| Press release | VolitionRx Limited Schedules Full Fiscal Year 2025 Earnings Conference Call and Business Update |
| Press release | VolitionRx Limited Announces Third Quarter 2025 Financial Results and Business Update |
| Press release | VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update |
| Press release | VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update |
| Press release | VolitionRx Limited Schedules Second Quarter 2025 Earnings Conference Call and Business Update |
| Press release | VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update |
| Press release | VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update |
| 2025-03-31 | Press release | VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update |
| 2025-03-31 | Press release | Earnings Release FY 2024 PDF |
| 2024-11-14 | Press release | VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update |
| 2024-11-14 | Press release | Earnings Release Q3 2024 PDF |
| 2024-11-08 | Press release | VolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business Update |
| 2024-08-14 | Press release | Earnings Release HTML |
| 2024-08-14 | Press release | Earnings Release Q2 2024 PDF |
| 2024-05-13 | Press release | Earnings Release HTML |
| 2024-03-25 | Press release | Earnings Release HTML |
| 2023-11-14 | Press release | Earnings Release HTML |
| 2023-08-14 | Press release | Earnings Release HTML |
| 2023-05-10 | Press release | Earnings Release HTML |
| 2023-03-15 | Press release | Earnings Release HTML |
| 2022-11-14 | Press release | Earnings Release HTML |
| 2022-08-10 | Press release | Earnings Release HTML |
| 2022-05-11 | Press release | Earnings Release HTML |
| 2022-03-30 | Press release | Earnings Release HTML |